Table 1.
Clinical characteristics of IBD patients.
| Blood | Intestinal biopsy | |||||
|---|---|---|---|---|---|---|
| HC | CD (A/R)b | UC (A/R)b | HC | CD (A/R)b | UC (A/R)b | |
| Patients | 24 | 26/22 | 28/16 | 10 | 15/7 | 12/0 |
| Age (yrs) | 52.5 ± 18 | 25.6 ± 6.8 | 41 ± 10 | 48.7 ± 17.4 | 24.7 ± 5.6 | 41.6 ± 11.7 |
| Gender (F/M) | 15/9 | 28/20 | 26/16 | 4/6 | 12/10 | 4/6 |
| Duration (months) | 28 ± 26.7 | 63.6 ± 46.2 | 27.5 ± 32 | 46.8 ± 28.5 | ||
| Current therapy | ||||||
| 5-ASA | 39 | 40 | 22 | 10 | ||
| Immunosuppressants | 27 | 14 | 5 | 4 | ||
| Biologics | 0 | 0 | 0 | 0 | ||
| Disease extenta | ||||||
| E1 | 5 | |||||
| E2 | 22 | 3 | ||||
| E3 | 17 | 9 | ||||
| Disease locationa | ||||||
| L1 | 4 | 0 | ||||
| L2 | 16 | 5 | ||||
| L3 | 28 | 17 | ||||
| L4 | 0 | 0 | ||||
aMontreal classification; bA/R, active/remission.